Richard Aranda, M.D.

Richard Aranda, M.D.

Chief Medical OfficeratGossamer Bio· In proxies 2023–2024

Pay in FY2024+3% from the year before · Gossamer Bio stock -0.9% the same year

Richard Aranda, M.D. was paid $1.1M in FY2024 (Dec), up 3%. Gossamer Bio stock fell 0.9% that year.

Pay$100 in the stock at the end of FY22 → $42
Pay is from the Summary Compensation Table of each Gossamer Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Gossamer BioPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?